Source:http://linkedlifedata.com/resource/pubmed/id/19656550
Switch to
Predicate | Object |
---|---|
rdf:type | |
lifeskim:mentions | |
pubmed:issue |
11
|
pubmed:dateCreated |
2009-10-19
|
pubmed:abstractText |
A total of 50 neuroblastomas were assessed for frequency of ALK gene copy number aberrations by interphase fluorescence in situ hybridization using a break-apart fluorescence in situ hybridization probe. The data were compared with status of MYCN, 11q, 17q, and 1p36. We observed ALK aberrations (amplification, 1 of 45; gain, 15 of 45 and loss/imbalance, 11 of 45) in a total of 27 (60%) of 45 neuroblastomas. Synchronic MYCN and ALK aberrations accounted for 23 of 45 (51%) tumors; however, MYCN alterations were also detected in 11 (60%) of 18 tumors without ALK aberrations. Our data suggest that copy number aberrations of the ALK gene is a frequent genetic event in the development of neuroblastomas. In addition, no correlation was observed between ALK aberrations and alterations of 11q, 17q, and 1p36.
|
pubmed:language |
eng
|
pubmed:journal | |
pubmed:citationSubset |
IM
|
pubmed:chemical |
http://linkedlifedata.com/resource/pubmed/chemical/MYCN protein, human,
http://linkedlifedata.com/resource/pubmed/chemical/Nuclear Proteins,
http://linkedlifedata.com/resource/pubmed/chemical/Oncogene Proteins,
http://linkedlifedata.com/resource/pubmed/chemical/Protein-Tyrosine Kinases,
http://linkedlifedata.com/resource/pubmed/chemical/Receptor Protein-Tyrosine Kinases,
http://linkedlifedata.com/resource/pubmed/chemical/anaplastic lymphoma kinase
|
pubmed:status |
MEDLINE
|
pubmed:month |
Nov
|
pubmed:issn |
1532-8392
|
pubmed:author | |
pubmed:issnType |
Electronic
|
pubmed:volume |
40
|
pubmed:owner |
NLM
|
pubmed:authorsComplete |
Y
|
pubmed:pagination |
1638-42
|
pubmed:dateRevised |
2011-11-17
|
pubmed:meshHeading |
pubmed-meshheading:19656550-Gene Dosage,
pubmed-meshheading:19656550-Humans,
pubmed-meshheading:19656550-In Situ Hybridization, Fluorescence,
pubmed-meshheading:19656550-Neuroblastoma,
pubmed-meshheading:19656550-Nuclear Proteins,
pubmed-meshheading:19656550-Oncogene Proteins,
pubmed-meshheading:19656550-Protein-Tyrosine Kinases,
pubmed-meshheading:19656550-Receptor Protein-Tyrosine Kinases,
pubmed-meshheading:19656550-Tissue Array Analysis
|
pubmed:year |
2009
|
pubmed:articleTitle |
Aberrant copy numbers of ALK gene is a frequent genetic alteration in neuroblastomas.
|
pubmed:affiliation |
Department of Pathology, Medical School, University of Valencia, 46010 Valencia, Spain.
|
pubmed:publicationType |
Journal Article,
Research Support, Non-U.S. Gov't
|